Medi-Cal now covering Merck's commercial COVID-19 antiviral Lagevrio

DHCS recently announced that Merck’s new commercial Lagevrio (molnupiravir) COVID-19 anti-viral drug is now a covered Medi-Cal Rx benefit.

Los Angeles psychiatrist George Fouras, M.D., elected vice speaker of the CMA House of Delegates

Los Angeles psychiatrist George Fouras, M.D., was newly elected as vice speaker of the California Medical Association (CMA) House of Delegates at the association’s annual meeting this past weekend. He will join Speaker Jack Chou, M.D. , on the dais to lead delegates as they shepherd resolutions into successful policy.

DHCS system issue caused erroneous denials of four COVID-19 vaccine admin codes

CMA has been made aware of a DHCS system issue that caused erroneous denials for four COVID-19 vaccine administration codes approved for use on April 18, 2023.  The system issue affected all claims submitted with these four codes. DHCS updated its system at the end of September 2023 and advised that an Erroneous Payment Correction (EPC) will be implemented to automatically reprocess the claims that erroneously denied with RAD Code 0037. CMA is waiting to hear back from DHCS on the timing o...

More News »